stockrowCencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Revenue growth
Cencora, Inc.'s revenue growth over the twelve months to 30 September 2026 was 5.00%. Over the past ten years it has ranged from 4.29% (fiscal 2017) to 13.7% (fiscal 2015); the current reading is higher than 17% of that period. That is below the Medical Distribution industry median of 6.15% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 5.00% | (4.31) |
| FY2025 | 9.31% | (2.81) |
| FY2024 | 12.1% | 2.23 |
| FY2023 | 9.89% | (1.61) |
| FY2022 | 11.5% | (1.19) |
| FY2021 | 12.7% | 6.95 |
| FY2020 | 5.74% | (1.20) |
| FY2019 | 6.94% | (2.72) |
| FY2018 | 9.66% | 5.37 |
| FY2017 | 4.29% | (3.72) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 5.52% | 0.45 |
| Jun 2026 | 5.07% | 1.22 |
| Mar 2026 | 3.85% | (1.60) |
| Dec 2025 | 5.45% | (0.47) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| AHG Akso Health Group Sponsored ADR compare | 208.4% |
| COSM Cosmos Health Inc. compare | 33.8% |
| FOCL FocalTherics compare | 29.5% |
| CAH Cardinal Health, Inc. compare | 10.0% |
| MCK McKesson Corporation compare | 8.19% |
| HSIC Henry Schein, Inc. compare | 6.15% |
| COR Cencora, Inc. | 5.00% |
| ACH Accendra Health, Inc. compare | −3.30% |
| YI 111, Inc. Sponsored ADR compare | −16.2% |
| Medical Distribution industry median | 6.15% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Beneish M-score
- The full statement